Physician profile
Jose A Ortega
NPI 1376742833
$32,281.02
in general payments reported to CMS, 2019-2025
90 companies · $5,533 in 2025
The $5,533 reported for 2025 was more than what 83% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,243 · 2020: $2,872 · 2021: $3,728 · 2022: $5,040 · 2023: $4,517 · 2024: $6,350 · 2025: $5,533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Long Term Medical Supply Or Device Loan: $2,283 · Education: $510 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,493.28 |
| Long Term Medical Supply Or Device Loan | $2,282.65 |
| Education | $509.81 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $113.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $3,078.94 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $2,284.11 | 2019-2025 | Tagrisso, Imfinzi, Enhertu |
| Genzyme Corporation | $1,679.96 | 2019-2025 | |
| Pfizer INC. | $1,570.57 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,496.30 | 2019-2025 | Opdivo, Opdualag, Reblozyl |
| Merck Sharp & Dohme LLC | $1,275.15 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Sirtex Medical INC | $1,219.76 | 2019-2023 | Sir-Spheres Microspheres |
| Celgene Corporation | $1,209.90 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Janssen Biotech, INC. | $1,048.41 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Seagen INC. | $973.72 | 2019-2023 | Tukysa, Tivdak, Padcev |
| Amgen INC. | $939.78 | 2019-2025 | Imdelltra (Amg757), Lumakras |
| Astellas Pharma US INC | $774.35 | 2019-2025 | Xtandi, Vyloy, Padcev |
| Tempus Ai, INC | $751.24 | 2024-2025 | Xt Cdx |
| Abbvie INC. | $663.17 | 2019-2025 | |
| Genentech USA, INC. | $645.03 | 2019-2025 | Polivy, Lunsumio, Venclexta |
Show all 90 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $605.83 | 2019-2025 | Jakafi, Monjuvi, Zynyz |
| Lilly USA, LLC | $584.78 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Puma Biotechnology, INC. | $564.25 | 2019-2025 | Nerlynx |
| Alexion Pharmaceuticals, INC. | $517.58 | 2019-2025 | Ultomiris, Soliris |
| Exelixis INC. | $502.41 | 2019-2025 | Cabometyx |
| Daiichi Sankyo INC. | $455.69 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Eisai INC. | $425.13 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $420.22 | 2021-2025 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $419.46 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Stemline Therapeutics INC. | $400.06 | 2022-2025 | Orserdu |
| Boehringer Ingelheim Pharmaceuticals, INC. | $360.48 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $359.99 | 2021-2025 | |
| Dova Pharmaceuticals | $357.92 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $345.17 | 2019-2025 | |
| Glaxosmithkline, LLC. | $338.26 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Novocure INC. | $297.43 | 2021-2025 | Optune Lua (Novottf-200t), Optune |
| Aveo Pharmaceuticals, INC. | $267.86 | 2022-2025 | Fotivda |
| Sobi, INC | $260.72 | 2022-2025 | |
| Kite Pharma, INC. | $246.44 | 2020-2024 | Yescarta |
| Biogen, INC. | $242.65 | 2019 | |
| Tg Therapeutics, INC. | $231.33 | 2021-2022 | |
| Array Biopharma INC | $212.16 | 2022-2025 | Braftovi, Lorbrena, Mektovi |
| Emd Serono, INC. | $208.33 | 2021-2025 | Bavencio, Tepmetko |
| Mirati Therapeutics, INC. | $195.96 | 2023-2024 | Krazati |
| Karyopharm Therapeutics INC. | $192.42 | 2020-2025 | Xpovio |
| Ipsen Biopharmaceuticals, INC | $186.51 | 2019-2025 | Onivyde, Somatuline Depot |
| Taiho Oncology, INC. | $178.35 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $167.51 | 2019-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $162.94 | 2019-2022 | |
| Caris Mpi, INC. | $162.19 | 2025 | Mi Cancer Seek |
| Alnylam Pharmaceuticals INC. | $161.45 | 2022-2024 | Givlaari |
| Coherus Oncology, INC. | $144.77 | 2020-2022 | |
| Ethicon INC. | $139.53 | 2020-2021 | |
| G1 Therapeutics, INC. | $136.08 | 2022-2023 | Cosela |
| Rigel Pharmaceuticals, INC. | $127.80 | 2020-2024 | Tavalisse, Rezlidhia |
| Ucb, INC. | $125.00 | 2025 | Briviact |
| Pharmacosmos Therapeutics INC. | $123.03 | 2024-2025 | Monoferric, Cosela |
| Teva Pharmaceuticals USA, INC. | $116.68 | 2019 | |
| Foundation Medicine, INC. | $113.18 | 2023 | |
| Adaptive Biotechnologies Corporation | $100.78 | 2023-2025 | Clonoseq |
| Sanofi-Aventis U.S. LLC | $99.95 | 2023 | |
| Deciphera Pharmaceuticals INC. | $99.48 | 2020-2024 | Qinlock |
| Global Blood Therapeutics, INC. | $98.90 | 2020-2022 | |
| Tersera Therapeutics LLC | $94.60 | 2023-2025 | Zoladex |
| Servier Pharmaceuticals LLC | $93.69 | 2025 | |
| Avyxa Pharma, LLC | $91.46 | 2025 | |
| Recordati_rare_diseases_inc. | $57.99 | 2022-2024 | Sylvant |
| Clovis Oncology, INC. | $54.08 | 2021 | |
| Conmed Corporation | $53.52 | 2024 | Airseal |
| Sun Pharmaceutical Industries INC. | $50.80 | 2019-2024 | |
| Amneal Pharmaceuticals LLC | $45.70 | 2025 | Alymsys |
| Octapharma USA, INC. | $45.56 | 2022-2023 | Panzyga |
| Beone Medicines USA, INC. | $44.94 | 2025 | Brukinsa |
| Amag Pharmaceuticals, INC. | $44.23 | 2019-2020 | |
| Blueprint Medicines Corporation | $42.99 | 2023-2024 | Ayvakit |
| Immunogen, INC. | $42.78 | 2023 | Elahere |
| Mylan Institutional INC. | $37.52 | 2019-2022 | |
| Beigene USA, INC. | $35.89 | 2022-2024 | Brukinsa |
| Agios Pharmaceuticals, INC. | $34.88 | 2025 | Pyrukynd |
| Immunocore Limited | $33.31 | 2025 | Kimmtrak |
| Adc Therapeutics America, INC. | $32.84 | 2023 | |
| Legend Biotech USA INC. | $27.31 | 2025 | Carvykti |
| Kyowa Kirin, INC. | $27.26 | 2023 | Poteligeo |
| Pharmaessentia USA Corporation | $26.67 | 2022 | |
| Tolmar, INC. | $24.96 | 2023 | |
| Blue Earth Diagnostics | $23.77 | 2023 | |
| Eusa Pharma (US) LLC | $22.30 | 2022 | |
| Morphosys, US INC. | $21.63 | 2023 | Monjuvi |
| Advanced Accelerator Applications | $19.26 | 2019 | |
| Accord Healthcare, INC. | $17.33 | 2023 | |
| Fortovia Therapeutics, INC. | $16.95 | 2020 | |
| Apellis Pharmaceuticals, INC. | $15.84 | 2024 | Empaveli |
| Myovant Sciences INC. | $13.78 | 2021 | |
| Acceleron Pharma, INC. | $11.94 | 2020 | |
| Pharmaand Gmbh | $8.19 | 2025 | Rubraca |
Drugs and devices associated with these payments
Kisqali $2,115Xt Cdx $751Sarclisa $747Sir-Spheres Microspheres $565Keytruda $493Reblozyl $439Enhertu $383Opdivo $365Lynparza $334Libtayo $303Xtandi $286Tagrisso $284Pomalyst $269Venclexta $262Tukysa $258Botox $253Imfinzi $242Jaypirca $235Ibrance $231Krazati $216Erleada $215Fotivda $207Cabometyx $195Lorbrena $189Bosulif $185Carvykti $178Yescarta $176Jevtana $175Lenvima $171Braftovi $169Elrexfio $166Verzenio $165Mi Cancer Seek $162Rybrevant $159Optune Lua (Novottf-200t) $152Adcetris $148Mektovi $147Tivdak $145Xpovio $139Ojjaara $130Elahere $130Lonsurf $129Inqovi $129Talzenna $127Orgovyx $126Briviact $125Inlyta $124Padcev $123Imdelltra (Amg757) $121Fruzaqla $117Givlaari $115Alunbrig $103Clonoseq $101Monoferric $100Tavalisse $97.95Rezlidhia $97.95Ultomiris $97.03Zoladex $94.60Opdualag $93.95Retevmo $92.49Onivyde $92.26Cyclophosphamide $91.46Posfrea $91.46Docivyx $91.46Axtle $91.46Vonjo $89.95Oxbryta $88.61Orserdu $88.42Bavencio $87.88Darzalex $87.85Soliris $85.00Comirnaty $83.11Jemperli $82.62Zejula $82.62Paxlovid $81.59Jakafi $79.59Pluvicto $77.63Nerlynx $76.11Polivy $74.71Talvey $74.17Brukinsa $64.79Qinlock $61.57Xalkori $57.41Akeega $56.54Airseal $53.52Imbruvica $49.90Monjuvi $46.28Lunsumio $46.26Alymsys $45.70Cosela $43.79Somatuline Depot $43.71Ayvakit $42.99Besponsa $42.63Enjaymo $41.02Cablivi $41.02Epkinly $36.22Sylvant $35.69Calquence $35.27Augtyro $35.00Pyrukynd $34.88
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Ortega listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.